The Swedish Medical Product Agency (Läkemedelsverket) has approved an application from Inhalation Sciences (ISAB) for a clinical trial of its PreciseInhale aerosol generation system, the company said. ISAB expects to initiate the trial in June 2021 and to complete the study by the end of the year. Inhalation Sciences first announced its intentions to validate … [Read more...] about Inhalation Sciences gets approval for PreciseInhale trial
Products and Services
Vectura to be acquired by the Carlyle Group
A newly formed company called Murano Bidco, which is controlled by the Carlyle Group, has agreed to pay approximately £958 million to acquire inhalation CDMO Vectura, the companies have announced. According to the announcement, Bidco was formed specifically for the purpose of acquiring Vectura. Vectura Chairman Bruno Angelici commented, "Vectura has made strong … [Read more...] about Vectura to be acquired by the Carlyle Group
Inhalation Sciences forms new scientific advisory board
Aerosol research instrument company Inhalation Sciences (ISAB) has announced the formation of a new scientific advisory board, which will begin meeting on June 1, 2021 to discuss how the company's PreciseInhale laboratory aerosol dosing system can be used once it has been validated for clinical use. Members of the new scientific advisory board include Carsten Ehrhardt … [Read more...] about Inhalation Sciences forms new scientific advisory board
Kindeva partners with Loughborough on low-GWP MDI propellants
Kindeva Drug Delivery (formerly 3M Drug Delivery Systems) has signed a knowledge transfer partnership (KTP) with Loughborough University for the development of lower GWP MDI propellants, the company announced. Kindeva says that it "will leverage the KTP to understand the physics involved in pharmaceutical spray generation, using computational fluid dynamic (CFD) … [Read more...] about Kindeva partners with Loughborough on low-GWP MDI propellants
Iconovo announces deal with Respiratorius for development of DPI
Iconovo will develop a dry powder formulation and a DPI for Phase 1 studies for Swedish respiratory drug company Respiratorius AB on a fee for service basis in a deal worth up to SEK 3 million, the company said. The project, which involves development of Respiratorius's RES030-085 for the treatment of COPD and severe asthma, would lead to a license agreement if … [Read more...] about Iconovo announces deal with Respiratorius for development of DPI
Koura launches HFA-152a development services
MDI propellant maker Koura has announced the launch of HFA-152a development and filling services at the company's facilities in Chester, UK. Koura (formerly Mexichem) first announced the possibility of using 152a as a low global warming potential (GWP) propellant for metered dose inhalers in 2016. In December 2019, Chiesi announced that it planned to bring a … [Read more...] about Koura launches HFA-152a development services
Iconovo announces expansion of deal with Amneal on generic Symbicort and launch of pharma division
DPI developer Iconovo has announced that its development deal with Amneal for a generic version of Symbicort has been amended to add US and Chinese marketing rights for Amneal and Nordic region marketing rights for Iconovo. Acquisition of the Nordic marketing rights also marks the launch of a new division of Iconovo, Iconovo Pharma. The original deal included … [Read more...] about Iconovo announces expansion of deal with Amneal on generic Symbicort and launch of pharma division
Proveris Scientific adds services for unit dose nasal spray testing
Proveris Scientific has announced that it now has the ability to conduct in vitro testing of unit dose nasal drugs in multiple orientations, which is necessary for intranasal products such as opioid overdose reversal drugs, seizure medications, or sedatives that are designed for administration by emergency personnel or clinicians where the patients could be in various … [Read more...] about Proveris Scientific adds services for unit dose nasal spray testing
Vectura to develop inhaled formulation of Inspira candidate for the treatment of COVID-19
Inhalation CDMO Vectura has signed an agreement with Inspira Pharmaceuticals to develop an inhaled formulation of a plant extract Inspira is developing for the treatment of COVID-19, the company said. Vectura will create a version of the IPX formulation to be delivered via Vectura's Fox vibrating mesh nebulizer for Phase 1 trials. Inspira is looking to raise £350,000 … [Read more...] about Vectura to develop inhaled formulation of Inspira candidate for the treatment of COVID-19
Oxford Lasers contract services facility gets ISO/IEC 17025:2017 accreditation
Oxford Lasers has announced that its Didcot, UK contract services facility has received ISO/IEC 17025:2017 accreditation from the UK Accreditation Service. The company opened the imaging facility for contract testing of aerosol delivery devices in 2019 and expanded the facility in 2020. Seamus Murphy, Manager of the Imaging Division, commented, “The UKAS … [Read more...] about Oxford Lasers contract services facility gets ISO/IEC 17025:2017 accreditation